KILL New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)
By:
Business Wire
January 26, 2024 at 03:17 AM EST
Genentech requests that their press release NewsItemId: 20240125093104 “New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)” be killed.
The release was issued prematurely by Genentech.
A replacement release will be issued at a later date.
Contacts
Media Contact:
Shirley Dang, (650) 467-6800
Advocacy Contact:
Danielle Haney, (240) 805-4810
Investor Contacts:
Loren Kalm, (650) 225-3217
Bruno Eschli, +41 61 687 5284
More News
View More
Keysight Technologies' Surge: The Market Wakes Up to This AI Play ↗
November 27, 2025
Is American Express the Credit Stock For a K-Shaped Economy? ↗
November 27, 2025
Via MarketBeat
Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions ↗
November 27, 2025
Is CrowdStrike Ready to Rally After Its Recent Pullback? ↗
November 27, 2025
Via MarketBeat
Tickers
CRWD
SanDisk Joins the S&P 500: Inside the Index Effect Rally ↗
November 27, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>